References
- Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020 Mar 19;91(1):157–160.
- WHO. Draft landscape of COVID-19 candidate vaccines. cited 2021 Nov 12 Available: https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines
- Ritchie H, Mathieu E, Rodés-Guirao L, et al. (2020) - “Coronavirus Pandemic (COVID-19)”. Available: OurWorldInData.org. cited 2021 Nov 12. Available from: https://ourworldindata.org/coronavirus
- WHO. COVAX. Working for global equitable access to COVID-19 vaccines. cited 2021 Nov 12. Available from: https://www.who.int/initiatives/act-accelerator/covax
- So AD, Woo J. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis. BMJ. 2020;371:m4750.
- McAdams D, McDade KK, Ogbuoji O. Incentivizing wealthy nations to participate in the COVID-19 vaccine global access facility (COVAX): a game theory perspective. BMJ Glob Health. 2020;5:e003627.
- Bright B, Babalola CP, Sam-Agudu NA. COVID-19 preparedness: capacity to manufacture vaccines, therapeutics and diagnostics in sub-Saharan Africa. Global Health. 2021;17:24.
- NCDC. First case of Corona virus disease confirmed in Nigeria. cited 2021 Nov 12. Available from: https://ncdc.gov.ng/news/227/first-case-of-corona-virus-disease-confirmed-in-nigeria
- Covid-19: A Perspective on Africa’s Capacity and Response. doi: 10.1002/jmv.26159
- Plotkin SA, Plotkin SL. The development of vaccines: how the past led to the future. Nat Rev Microbiol. 2011 Oct 3;9(12):889–893.
- Excler J-L, Privor-Dumm L, Kim JH. Supply and delivery of vaccines for global health. Curr Opin Immunol. 2021;71:13–20.
- United Nations General Assembly. Resolution 74/274: international cooperation to ensure global access to medicines, vaccines and medical equipment to face COVID-19. New York: United Nations; 2020. cited 2021 Nov 01. Available from: https://undocs.rg/en/A/RES/74/274
- WHO. Africa COVID-19 dashboard. Accessed 2021 Nov 12. Available from: https://app.powerbi.com/view?r=eyJrIjoiY2ViYzIyZjItYzhkMi00ZWVkLTgyM2ItZTk1ZTJmODRjMTkxIiwidCI6ImY2MTBjMGI3LWJkMjQtNGIzOS04MTBiLTNkYzI4MGFmYjU5MCIsImMiOjh9
- WHO. The access to COVID-19 tools (ACT) accelerator. Accessed 2021 Nov 12. Available from: https://www.who.int/initiatives/act-accelerator
- Eccleston‐Turner M, Upton H. International collaboration to ensure equitable access to vaccines for COVID-19: the ACT-accelerator and the COVAX facility. Milbank Q. 2021;99(2):426–449.
- WHO’s allocation framework for COVAX: is it fair? Current controversy. AstraZeneca. Agreements with CEPI and Gavi and the Serum Institute of India will bring vaccine to low and middle-income countries and beyond. Press release, 2020 Jun 4. Accessed 2021 Nov 12. Available from: https://www.astrazeneca.com/media-centre/press-releases/2020/astrazeneca-takes-next-steps-towards-broad-and-equitable-access-to-oxford-universitys-covid-19-vaccine.html
- Gavi the Vaccine Alliance. New collaboration makes further 100 million doses of COVID-19 vaccine available to low- and middle-income countries. Press release, 2020 Sept 29. cited 2021 Nov 12. Available from: https://www.gavi.org/news/media-room/new-collaboration-makes-further-100-million-doses-covid-19-vaccine-available-low
- Goodman PS, Thomas K, Wee S-L, et al. A new front for nationalism: the global battle against a virus. New York Times, 2020. cited 2021 Nov 12. Available from: https://www.nytimes.com/2020/04/10/business/coronavirus-vaccine-nationalism.html
- Bollyky TJ, Bown CP The tragedy of vaccine nationalism, 2020. Accessed 2021 Nov 12. Available from: https://www.foreignaffairs.com/articles/united-states/2020-07-27/vaccine-nationalism-pandemic
- Gostin LO, Karim SA, Meier BM. Facilitating access to a COVID-19 vaccine through global health law. J Law Med Ethics. 2020;48(3):622–626.
- Our World in Data. Cumulative COVID-19 vaccinations per 100 people. cited 2021 Nov 12. Available from: https://ourworldindata.org/grapher/covid-vaccination-doses-per-capita
- Our World in Data. COVID-19 vaccine doses administered. cited 2021 Nov 12. Available from: https://ourworldindata.org/grapher/cumulative-covid-vaccinations
- World Health Organization (WHO). Fair allocation mechanism for COVID-19 vaccines through the COVAX facility. 2020
- World Health Organization (WHO). Who SAGE values framework for the allocation and prioritization of COVID-19 vaccination. 2020
- World Health Organization (WHO). WHO Africa. Coronavirus (COVID-19). Accessed 2021 Nov 12. Available from: https://www.afro.who.int/health-topics/coronavirus-covid-19
- Ophori EA, Tula MY, Azih AV, et al. Current trends of immunization in Nigeria: prospect and challenges. Trop Med Health. 2014;42(2):67–75.
- Babalola S, Olabisi A. Community and systematic factors affecting the uptake of immunization in Nigeria: a quantitative study in five states. Nigeria; Abuja: Department of International Development (DFID); 2004.
- Green C. Demand for Immunization and IMCI in Nigeria: an issues paper. In: Background paper prepared for the PATHS Immunization and IMCI roundtable. Final version. Abuja: Partnership for Transforming Health Systems (PATHS); 2004.
- World Health Organization (WHO). Module 5: vaccine sfety institutions and mechanisms. cited 2021 Nov 12. Available from: https://vaccine-safety-training.org/national-immunization-programmes.html
- Balogun FM. The state of adolescent immunization in Nigeria: a wake up call for all stakeholders. Pan Afr Med J. 2019 Aug 13;33:294.
- Stevens W, Walker D. Adolescent vaccination in the developing world: time for serious consideration? Vaccine. 2004 Jan 26;22(5–6):781–785.
- Omondi-Ogutu M, Imunya JM. Parental acceptance of human papillomavirus vaccine for their pre-pubertal and teenage daughters. East Afr Med J. 2011;88(5):163–170.
- Ogundele OA, Omotosho AA. Vaccination of healthcare workers in Nigeria: a review of barriers, policies and level of implementation. Libyan J Med Sci. 2020;4:9–15.
- Ogundele OA. Reducing the risk of nosocomial Hepatitis B virus infections among healthcare workers in Nigeria: a need for policy directive on pre-employment screening and vaccination. Pan Afr Med J. 2018;30:133.
- Adejumo OA, Ogundele OA, Madubuko CR, et al. Perceptions of the COVID-19 vaccine and willingness to receive vaccination among health workers in Nigeria. Osong Public Health Res Perspect. 2021;12(4):236–243.
- WHO Coronavirus Disease (COVID-19) Dashboard [Internet]. WHO (World Heal. Organ. 2021. cited 2021 Nov 12. Available from: https://covid19.who.int/
- Kashte S, Gulbake A, El-Amin SF, et al. COVID-19 vaccines: rapid development, implications, challenges and future prospects. Hum Cell. 2021;34(3):711–733.
- Nigeria: COVID-19 vaccine rollout kicks off in Africa’s most populous country. cited 2021 Nov 12. Available from: https://www.un.org/africarenewal/magazine/april-2021/nigeria-covid-19-vaccine-rollout-kicks-africas-most-populous-country
- COVID-19 vaccines shipped by COVAX arrive in Nigeria. cited 2021 Nov 12. Available from: https://www.unicef.org/nigeria/press-releases/covid-19-vaccines-shipped-covax-arrive-nigeria
- The Guardian. COVID-19: FG officially ends first phase of vaccination - NPHCDA | the Guardian Nigeria news - Nigeria and World News [Internet]. The Guardian Nigeria News - Nigeria and World News (2021). Accessed 2021 Nov 12. Available from: https://guardian.ng/news/covid-19-fg-officially-ends-first-phaseof-vaccination-nphcda/
- World Health Organization (WHO) (2021). Nigeria receives 177,600 doses of Johnson & Johnson vaccines for next phase of COVID-19 vaccinations. Accessed 2021 Nov 12. Available from: https://www.afro.who.int/news/nigeria-receives-177600-doses-johnson-johnson-vaccines-next-phase-covid-19-vaccinations
- Nigeria administers 5.7 million COVID-19 vaccines, targets 70% population 2022. cited 2021 Nov 12. Available from: https://www.premiumtimesng.com/news/headlines/494207-nigeria-administers-5-7-million-covid-19-vaccines-targets-70-population-2022.html
- Strengthening civil society’s response to COVID-19 in Nigeria. cited 2022 Mar 11. Available from: https://www.macfound.org/press/grantee-news/strengthening-civil-societys-response-covid-19-nigeria
- Nigerian diaspora COVID-19 response in the homeland; Valuing the gift of community. cited 2022 Mar 11. Available from: https://www.globalpeace.org/blog/nigerian-diaspora-covid-19-response-homeland-valuing-gift-community
- COVID-19: NSSF to vaccinate 1 million vulnerable Nigerians, says Chinye-Nwoko. cited 2021 Nov 12. Available from: https://www.vanguardngr.com/2021/08/covid-19-nssf-to-vaccinate-1-million-vulnerable-nigerians-says-chinye-nwoko/
- COVID-19: vaccination to cost N6,000 in Lagos as state-owned centre charges N350,000 per day for treatment. cited 2021 Nov 12. Available from: https://www.premiumtimesng.com/news/headlines/492149-covid-19-vaccination-to-cost-n6000-in-lagos-as-state-owned-centre-charges-n350000-per-day-for-treatment.html
- Harris RJ, Hall JA, Zaidi A, et al. Effect of vaccination on household transmission of SARS-CoV2 in England. N Engl J Med. published online. 2021 Jun 23;385(8):759–760.
- Haas EJ, Angulo FJ, McLaughlin JM, et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet. 2021;397(10287):1819–1829.
- Kampmann B, Okomo U. COVID-19 vaccines for children in LMICs: another equity issue. Lancet. 2021;398(10302):731–732.
- Irfan O, Muttalib F, Tang K, et al. Clinical characteristics, treatment and outcomes of paediatric COVID-19: a systematic review and meta-analysis. Arch Dis Child. 2021;106(5):440–448.
- Ismail SA, Saliba V, Bernal JL, et al. SARS-CoV-2 infection and transmission in educational settings: a prospective, cross-sectional analysis of infection clusters and outbreaks in England. Lancet Infect Dis. 2021;21(3):344–353.
- Skelton A, Forsberg L. 3 Reasons for making covid-19 vaccination mandatory for children. Conversation. 2021 May;13: https://theconversation.com/3-reasons-for-making-covid-19-vaccination-mandatory-for-children-160589
- Adeniran AO, Sidiq BO. Economic recession and the way-out: Nigeria as case study. Global J Hum-Soc Sci. 2018;18:181–192.
- Ozili P, COVID-19 in Africa: socio-economic impact, policy response and opportunities. Int J Sociol Soc Policy. 2020.
- Barnett-Howell Z, Mobarak A, 2020. The value of social distancing is not equally distributed. Vox multimedia. Accessed 2021 Nov 12. Available from: https://voxeu.org/article/value-social-distancing-not-equally-distributed
- Inegbedion HE. COVID-19 lockdown: implication for food security. J Agribus Dev Emerg Econom. 2020;11:437–451.
- Inegbedion H, Inegbedion E, Obadiaru E, et al. Cassava attractiveness in Nigeria: a policy improvement approach. J Agribus Dev Emerg Econ. 2020;10:157–175.
- International Chamber of Commerce 2020. The economic case for global vaccinations. cited 2021 Nov 12. Available from: https://iccwbo.org/publication/the-economic-case-for-global-vaccinations/
- Our World in Data. Nigeria: coronavirus Pandemic Country Profile. Accessed 2021 Nov 12. Available from: https://ourworldindata.org/coronavirus/country/nigeria
- Correlating WHO COVID-19 interim guideline 2020.5 and testing capacity, accuracy, and logistical challenges in Africa. cited 2021 Nov 12. Available fronm: https://www.panafrican-med-journal.com//content/article/39/89/full.
- Shey M, Okeibunor JC, Yahaya AA, et al. Genome sequencing and the diagnosis of novel coronavirus (SARS-COV-2) in Africa: how far are we? Pan Afr Med J. 2020 Jun 9;36:80.
- Nzaji MK, Mwamba GN, Miema JM, et al. COVID-19 pandemic – an African perspective. Emerg Microbes Infect. 2020;13:1215.
- Ondoa P, Kebede Y, Loembe MM, et al. COVID-19 testing in Africa: lessons learnt. Lancet Microbe. 2020 Jul;1(3):e103–e104.
- Kavanagh MM, Erondu NA, Tomori O, et al. Access to lifesaving medical resources for African countries: COVID- 19 testing and response, ethics, and politics. Lancet. 2020;395(10238):1735–1738.
- WHO. (2020). COVID-19 cases top 10,000 in Africa. cited 2021 Nov 12. Available from: https://www.afro.who.int/news/covid-19-cases-top-10-000-africa
- Institute for Health Metrics and Evaluation (IHME). Hybrid statistical/SEIR model Available. cited 2021 Nov 12. Available from: https://covid19.healthdata.org/
- Imperial College London (ICL). Age-structured SEIR model focused on low- and middle-income countries. cited 2021 Nov 12. Available from: https://mrc-ide.github.io/global-lmic-reports/
- Our World in Data. cited 2021 Nov 12. Available from: https://ourworldindata.org/grapher/covid-19-daily-tests-vs-daily-new-confirmed-cases?country=~NGA
- Africa Centres for Disease Control and Prevention. Africa CDC, FIND partner to build capacity for COVID-19 rapid diagnostic tests in Africa. 2020; cited 2021 Nov 12 Available from: https://africacdc.org/news-item/africa-cdc-find-partner-to-build-capacity-for-covid-19-rapid-diagnostic-tests-in-africa
- Duong YT, Wright CG, Justman J. Antibody testing for coronavirus disease 2019: not ready for prime time. BMJ. 2020;370:2655.
- Wadvalla BA. How Africa has tackled COVID-19. BMJ. 2020;370:2830.
- Musa HH, Musa TH, Musa IH, et al. Addressing Africa’s pandemic puzzle: perspectives on COVID-19 transmission and mortality in sub-Saharan Africa. Int J Infect Dis. 2021 Jan;102:483–488.
- Okpala OV, Dim CC, Ugwu CI, et al. Population seroprevalence of SARS-CoV-2 antibodies in Anambra State, South-East, Nigeria. Int J Infect Dis. 2021 Sep;110:171–178.
- Uyoga S, Adetifa IMO, Otiende M, et al. Prevalence of SARS-CoV-2 Antibodies From a National Serosurveillance of Kenyan Blood Donors, January-March 2021. JAMA. 2021 October 12;326(14):1436–1438. Erratum in: JAMA. 2021 Oct 26;326(16):1637.
- Chibwana MG, Jere KC, Kamn’gona R, et al. High SARS-CoV-2 seroprevalence in health care workers but relatively low numbers of deaths in urban Malawi. medRxiv [Preprint]. 2020 Aug 5:2020.07.30.20164970. Update in: This article has been published with DOI: 10.1101/2020.07.30.20164970.
- Nkengasong J. Let Africa into the market for COVID-19 diagnostics. Nature. 2020;580(7805):565.
- Kobia F, Gitaka J. COVID-19: are Africa’s diagnostic challenges blunting response effectiveness? AAS Open Res. 2020 Apr 17;3:4.
- Dixit S, Ogundeji YK, Onwujekwe O How well has Nigeria responded to COVID-19? Brooking: Future Development 2020. Accessed 2022 May 20. Available from: https://www.brookings.edu/blog/future-development/2020/07/02/how-well-has-nigeria-responded-to-covid-19/
- Why are Nigerians paying for fake COVID test results?. cited 2022 May 20. Available from: https://www.aljazeera.com/economy/2021/10/1/why-are-nigerians-paying-for-fake-covid-test-results
- World Health Organization Africa cited 2022 May 20. Available from: https://www.afro.who.int/news/flying-doctors-boost-nigerias-covid-19-testing
- COVID-19: daily tests vs. Daily new confirmed cases. Our World in Data. cited 2022 May 20. Available from: https://ourworldindata.org/grapher/covid-19-daily-tests-vs-daily-new-confirmed-cases?time=2020-01-25.2020-08-14&country=~NGA
- COVID-19 testing stops in 13 states, delta variant hitting unvaccinated Nigerians. Accessed 2022 May 20. Available from: https://punchng.com/covid-19-testing-stops-in-13-states-delta-variant-hitting-unvaccinated-nigerians/
- Fantastic step forward: first COVAX vaccines arrive in Nigeria. cited 2021 Mar 4. Available from: https://www.aljazeera.com/news/2021/3/2/millions-of-free-covax-jabs-arrive-in-nigeria
- Covid vaccines: why is Nigeria unable to use its supply?. cited 2022 Mar 8. Available from: https://www.bbc.com/news/59580982
- Nigeria receives 2 million doses of J&J COVID vaccine from EU countries. cited 2022 Mar 11. Available from: www.reuters.com/business
- COVID-19 vaccination in Nigeria cited 2022 Mar 3. Available from: https://en.wikipedia.org/w/index.php?title=COVID19_vaccination_in_Nigeria&action=edit§ion=13
- COVID-19: Nigeria, five other African countries get WHO approval for vaccine production. cited 2022 Mar 5. Available from: https://www.premiumtimesng.com/news/more-news/512356-covid-19-nigeria-five-other-african-countries-get-who-approval-for-vaccine-production.html
- Covid-19 vaccinations in Nigeria: what are the implications for international NGOs? cited 2022 Mar 9. Available from: https://gisf.ngo/blogs/covid-19-vaccinations-in-nigeria-what-are-the-implications-for-international-ngos/
- Tobin EA, Okonofua M, Adeke A, et al. Willingness to Accept a COVID-19 vaccine in Nigeria: a population-based cross-sectional study. Central Afr J Pub Health. 2021;7:53–60.
- Global citizen – 6 Things to Know About How Nigeria Is Distributing the COVID-19 Vaccine, online. cited 2021 Apr 10. available from: https://www.globalcitizen.org/en/content/things-toknow-nigeria-covid-vaccine-distribution/
- African Development Bank Group. African Economic Outlook 2020: africa’s economy forecast to grow despite external shocks. cited 2021 Nov 12. Available from: https://www.afdb.org/en/news-andevents/press-releases/african-economic-outlook-2020-africas-economy-forecast-grow-despite-externalshocks-33839
- Center for Global Development. The economic impact of COVID-19 in Africa: a round-up of this week’s analysis. cited 2021 Nov 12. Available from: https://www.cgdev.org/blog/economic-impact-covid-19-africa-weeks-latest-analysis
- DW. Africa. World Bank: no African country can face this crisis alone. cited 2021 Nov 12. Available from: https://www.dw.com/en/world-bank-no-africancountry-can-face-this-crisis-alone/a-53142901
- Bamgboye EL, Omiye JA, Afolaranmi OJ, et al. COVID-19 pandemic: is Africa different? J national med assoc. 2021;113:3.